Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908996 · ClinicalTrials.gov registry record · NA
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
A NA study of Overweight and Endometrial Cancer, sponsored by Sanford Health.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT03908996: Completed NA study of Overweight and Endometrial Cancer, sponsored by Sanford Health.
NCT03908996 is a NA study of Overweight and Endometrial Cancer that has completed, run by Sanford Health. The registered enrollment target is 25 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03908996, a NA study of Overweight and Endometrial Cancer, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of this study is to evaluate the effectiveness of a 12-month comprehensive weight management program on weight change in overweight/obese patients following treatment for endometrial cancer. During the study period, subjects will be monitored for recurrence during routine clinic visits A secondary exploratory purpose of this study will be to evaluate the gut microbiome in this intervention group and the changes that may occur while participating in a weight loss and weight management program.
Primary Outcome
All enrolled subjects will be weighed in pounds and the difference from baseline to 6 months will be recorded.
Conditions Studied
Interventions
- BEHAVIORAL Profile by Sanford weight management plan
Study Locations (2)
North Dakota
- Roger Maris Cancer Center - Fargo
South Dakota
- Sanford Gynecological Oncology clinic - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2021-01-11 |
| Phase | NA |
What the finished NCT03908996 record still lists
NCT03908996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Overweight appearing as the primary indexed condition, and to 1 intervention - of which Profile by Sanford weight management plan is the first listed.
NCT03908996 reports a single indexed study location in North Dakota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT03908996 about?
NCT03908996 is a clinical study titled "the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer". The primary purpose of this study is to evaluate the effectiveness of a 12-month comprehensive weight management program on weight change in overweight/obese patients following treatment for endometrial cancer. During the study period, subjects will be monitored for recurrence during routine clinic ...
What is the current status of trial NCT03908996?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-11. Estimated completion is 2021-01-11.
What conditions does trial NCT03908996 study?
This clinical trial studies the following conditions: Overweight, Endometrial Cancer.
What interventions are being tested in trial NCT03908996?
The interventions under investigation include: Profile by Sanford weight management plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT03908996?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03908996 being conducted?
This trial has 2 study locations across North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03908996's enrollment target sits among peer trials
25 176th of 197 higher than 20 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI